John Foster, MD
Family Medicine · Ronan, MTNPI 1588864979
Payments from drug & device makers
Across 37 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$90
- Astellas Pharma US Inc$80
- Boehringer Ingelheim$56
- AbbVie$48
- Amgen$48
- Exact Sciences$47
- plus $302 from 13 others
What the payments were for
- Food & beverage$671100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $90 |
| Astellas Pharma US Inc | 4 | $80 |
| Boehringer Ingelheim | 3 | $56 |
| AbbVie | 2 | $48 |
| Amgen | 2 | $48 |
| Exact Sciences | 2 | $47 |
| Sanofi Pasteur Inc. | 2 | $42 |
| AstraZeneca | 3 | $36 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Merck | 2 | $31 |
| Pfizer | 2 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Bayer | 1 | $12 |
| Roche Diagnostics Corporation | 1 | $12 |
How this compares
$671 in reported general payments places this provider in the 80th percentile of 426 family medicine providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 50 | $35,014 |
| EliquisApixaban | 36 | $24,746 |
| JardianceEmpagliflozin | 34 | $23,073 |
| OzempicSemaglutide | 17 | $15,685 |
| CreonLipase/Protease/Amylase | 12 | $11,856 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $9,883 |
| XareltoRivaroxaban | 13 | $9,041 |
| Spiriva RespimatTiotropium Bromide | 17 | $8,525 |
| Spiriva HandihalerTiotropium Bromide | 12 | $5,794 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,162 |
| MyrbetriqMirabegron | 12 | $4,989 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $3,756 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $3,371 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $2,985 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,668 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $31 | $35,01450 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $56 | $31,59851 claims |
| PfizerEliquis | $24 | $24,74636 claims |
| AbbVieCreon | $48 | $11,85612 claims |
| Astellas Pharma US IncMyrbetriq | $80 | $4,98912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 426 family medicine providers in Montana.
Other family medicine in Ronan
- Laura HogansonRonan$1K
- Megan VigilRonan$1K
- Edred VizcarraRonan$894
- Daniel MoulletRonan$728
- Aubrey RemmersMissoula$1.1M
- Justin BulsKalispell$829K
- Libby LakeGreat Falls$286K
- Kimberly BlakesleeMissoula$186K
- Jeanne Pereles OrtizBillings$78K
- Kathleen Harder-BrouwerHamilton$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.